ISSN:

Journal Home

BMC Biotechnology Q2 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

BMC Biotechnology is a journal indexed in SJR in Biotechnology with an H index of 99. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2090 €. The scope of the journal is focused on biotechnology. It has an SJR impact factor of 0,77 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,77.

BMC Biotechnology focuses its scope in these topics and keywords: agonist, alkaline, antibody, biobanked, cancer, cassettes, counterselectable, development, dna, edbtargeting, ...

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Biotechnology (Q2)

Price

2090 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,77

SJR Impact factor

99

H Index

105

Total Docs (Last Year)

163

Total Docs (3 years)

5296

Total Refs

678

Total Cites (3 years)

163

Citable Docs (3 years)

3.6

Cites/Doc (2 years)

50.44

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Biotechnology and Bioengineering Q2
World Journal of Microbiology and Biotechnology Q2
Journal of Industrial Microbiology and Biotechnology Q2
Journal of Basic Microbiology Q2
Biotechnology journal Q2

Compare this journals